— Know what they know.
Not Investment Advice

CTE.AX ASX

Cryosite Limited
1W: -1.7% 1M: -8.0% 3M: -8.0% YTD: -5.0% 1Y: +43.8% 3Y: +102.1% 5Y: +195.6%
A$1.15 ($0.80)
+0.00 (+0.00%)
 
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 42 · A$56.1M mcap · 7M float · 0.048% daily turnover

Balance Sheet Trends

Total Assets
$26M +33.4% ▲
5Y CAGR: +3.4%
Total Liabilities
$21M +23.7% ▲
5Y CAGR: -0.0%
Shareholders Equity
$5M +103.0% ▲
5Y CAGR: +42.7%
Cash & Investments
$2M -55.7% ▼
5Y CAGR: -10.4%
Total Debt
$8M +240.4% ▲
5Y CAGR: +48.6%
Net Debt
$5M +296.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$5M$5M$5M$5M$2M
Short-Term Investments$0$1M$0$0$0
Cash & ST Investments$5M$6M$5M$5M$2M
Net Receivables$1M$2M$1M$2M$3M
Inventory$47K$60K$59K$43K$57K
Other Current Assets$0$0$1M$1M$0
Total Current Assets$7M$8M$8M$9M$5M
Property, Plant & Equip.$2M$4M$4M$3M$14M
Goodwill & Intangibles$12K$8K$4K$0$14K
Long-Term Investments$36K$0$0$0$0
Other Non-Current Assets$11M$10M$7M$6M$6M
Total Non-Current Assets$14M$15M$12M$11M$21M
Total Assets$22M$23M$20M$19M$26M
— Liabilities —
Accounts Payable$460K$632K$657K$1M$888K
Short-Term Debt$0$0$0$0$220K
Deferred Revenue$2M$2M$2M$0$2M
Other Current Liabilities$520K$682K$557K$3M$905K
Total Current Liabilities$4M$4M$4M$5M$5M
Long-Term Debt$0$0$0$0$6M
Other Non-Current Liab.$1M$1M$1M$10M$948K
Total Non-Current Liabilities$16M$16M$14M$13M$16M
Total Liabilities$20M$20M$18M$17M$21M
— Equity —
Common Stock$6M$6M$4M$4M$4M
Retained Earnings-$4M-$3M-$2M-$1M$1M
Accumulated OCI$0$0$0$32K$258K
Total Stockholders Equity$2M$3M$1M$2M$5M
Total Liabilities & Equity$22M$23M$20M$19M$26M
— Key Metrics —
Total Debt$850K$3M$2M$2M$8M
Net Debt-$4M-$2M-$2M-$3M$5M
Total Investments$36K$1M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms